Investigators are not obligated to actively seek follow-up information for patients with adverse experience after the conclusion of the study (i.e., > 90 days after the FMT procedure). However, if the investigator becomes aware of an adverse experience that occurs after the patient completes and the adverse experience is considered by the Investigator to be at least possibly related to study procedure, the investigator must notify the University of Texas Health Science Center IRB.